1. Pessaaud T. The polka-dot sign. Radiology. 2008; 246(3):980-1.
2. Pastushyn AI, Slinko EI, Mirzoveva GM. Vertebral hemangiomas: diagnosis, management, natural history and clinicoathological correlates in 86 patients. Surg Neurol. 1999;50(6):535-47.
3. Han BK, Ryu JS, Moon DH, Shin MJ, Kim YT, Lee HK. Bone SPECT imaging of vertebral hemangioma correlation with MR imaging and symptoms. Clin Nucl Med. 1995;20(10):916-21.
4. Gerard PS, Wilck E. Spinal hemangioma. An unusual photopenic presentation on bone scan. Spine. 1976;17(5):607-10.
5. Halkar RK, Motawi MM, Hebbar HG, Jahan MS. Vertebral body hemangioma showing increased uptake of Tc-99m MDP and decreased Tc-99m labeled red blood cells. Clin Nucl Med. 1994;19(9):827-8.
6. Raphael J, Hephzibah J, Mani S, Shanthly N, Oommen R. Abnormal appearance of spinal hemangioma mimicking metastasis in bone scintigraphy and SPECT CT: a case report. J Nucl Med Radiat Ther. 2013;S6:16-8.
7. Bybel B, Raja S. Vertebral hemangioma on FDG PET scan. Clin Nucl Med. 2003;28(6):522-3.
8. Nakayama M, Okizaki A, Ishitoya S, Aburano T. “Hot” vertebra on FDG PET scan; a case of vertebral hemangioma. Clin Nucl Med. 2012;37(12):1990-3.
9. Feldman F, van Heertum R, Manus C. 18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol. 2003;32(4):201-8.
10. Kwee TC, de Klerk JMH, Nix M, Heggelman BGF, Dubois SV, Adams HJA. Benign bone conditions that may be FDG -avid and mimmic malignancy. Semin Nucl Med. 2017;47(4):322-51.
11. Itabashi T, Emori M, Terashima Y, Hasegawa T, Shimizu J, Nagoya S, et al. Hemangioma of the rib showing relatively high 18F-FDG uptake: a case report with a literature review. Acta Radiol Open. 2017;6(9):1-5.
12. Cha JG, Yoo JH, Kim HK, Park JM, Paik SH, Park SJ. PET/CT and MRI of intra-osseous hemangioma of the tibia. Br J Radiol. 2012;85(1012):e094-8.
13. Ko SW, Park JG. Cavernous hemangioma of the ilium mimmiking aggressive malignant bone tumor with increased activity on 18F-FDG/CT. Korean J Radiol. 2013;14(2):294-8.
14. Dupond JL, Mahammedi H, Prie D, Collin F, Gil H, Blagosklonov O, et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 FDG PET CT for the diagnosis and follow up in one case. Bone. 2005;36(3):375-8.
15. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59(8):1442-54.
16. Malhotra G, Agrawal A, Jambhekar NA, Sarathi V, Jagtap V, Agarwal MG, et al. Interesting image. The search for primary tumor in a patient with oncogenic osteomalacia: F-18 FDG PET resolves the conundrum. Clin Nucl Med. 2010;35(11):896-8.
17. Breer S, Brunkhorst T, Beil FT, Peldschus K, Heiland M, Klutmann S, et al. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumorinduced osteomalacia but negative 111In-octreotide SPECT/CT. Bone. 2014;64:222-7.
18. Taira AV, Herfkens RJ, Gambhir SS, Quan A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology. 2007;243(1):204-11.